Canasa 400 mg (Tablet (Delayed Release))
Unit Price: ৳ 5.00 (3 x 10: ৳ 150.00)
Strip Price: ৳ 50.00
Medicine Details
Category | Details |
---|---|
Generic | Mesalazine 5 aminosalicylic acid |
Company | Drug international ltd |
Title
- Canasa
Category
- Medicine
- Pharmaceutical
Indications
- Treatment of mild to moderately active Ulcerative Colitis & Crohn's Disease
- Maintenance of remission of Ulcerative Colitis
- Maintenance of remission of Crohn's disease
Pharmacology
- Mechanism of action is unknown
- Appears to be topical rather than systemic
- Diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon
Dosage & Administration
- Adult dosage: Up to 4 gm mesalazine once daily or divided into 2-4 doses for active disease
- Adult maintenance dosage: 2 gm mesalazine once daily
- Pediatric dosage: To be determined individually based on age and weight
- Granules must not be chewed, and the contents of the sachet should be emptied onto the tongue and washed down with water or orange juice
Interaction
- Concurrent use of nephrotoxic agents such as NSAIDs and Azathioprine may increase the risk of renal reactions
Contraindications
- Hypersensitivity to salicylates or any other component of the formulation
Side Effects
- Headache
- Nausea
- Dizziness
- Asthenia
- Dyspepsia
- Vomiting
- Pruritus
Pregnancy & Lactation
- Should be given in pregnancy only if the potential benefit justifies the potential risk to the fetus
- Caution advised when administered to a nursing mother
Precautions & Warnings
- Patients with pyloric stenosis may have prolonged gastric retention of Mesalamine tablets
- Renal impairment, including minimal change nephropathy and acute and chronic interstitial nephritis reported in patient
Use in Special Populations
- Geriatric patients should have blood cell counts closely monitored during Mesalamine therapy
- Elderly patients are more likely to have decreased renal function
- Safety and effectiveness in pediatric patients not established
Overdose Effects
- No specific antidote for Mesalamine overdose
- Treatment for suspected acute severe toxicity should be symptomatic and supportive
Therapeutic Class
- Aminosalicylates
Storage Conditions
- Store below 30 0 C
- Protect from light and moisture
- Keep out of reach of children
Related Brands
- Meslamin DR 400 mg (Tablet (Delayed Release)) - ibn-sina-pharmaceuticals-ltd
- Mesala 400 mg (Tablet (Delayed Release)) - nipro-jmi-pharma-ltd
- Cozycol 800 mg (Tablet (Delayed Release)) - square-pharmaceuticals-plc
- Pentasa 1 gm/sachet (Microgranules) - ferring-pharmaceuticals-ltd
- Pentasa 2 gm/sachet (Microgranules) - ferring-pharmaceuticals-ltd